Bionano Genomics Inc

Bionano Genomics Inc

BNGO

Get informed when a big investor buys or sells

+ Follow
Market Cap$13.09M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bionano Genomics IncBionano Genomics Inc-0.2--84%0.20.5
$1.11

Current Fair Value

1.9% downside

Overvalued by 1.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$13.09 Million
Enterprise Value$17.54 Million
Dividend Yield$- (-)
Earnings per Share$-4.85
Beta1.65
Outstanding Shares5,445,000

Return

Return on Equity-84.34%ROE
Return on Assets-48.76%
Return on Invested Capital-93.40%

Valuation & Multiples

P/E Ratio-0.2P/E Ratio
PEG-0.12PEG
Price to Sales0.23Price to Sales
Price to Book Ratio0.19Price to Book Ratio
Enterprise Value to Revenue0.61
Enterprise Value to EBIT-0.43
Enterprise Value to Net Income-1
Total Debt to Enterprise1.03
Debt to Equity0.48Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 13, 2026
EPS Estimate
$-0.81
Average shareholder expectation
Revenue Estimate
$6.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-0.70
Average shareholder expectation
Revenue Estimate
$7.48 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %15.99%▼ 0.59%
Total Invested$1.02M▼ 24.83%
Investors Holding300%

ESG Score

No data

About Bionano Genomics Inc

147 employees
CEO: R. Erik Holmlin